FDA Tentatively Approves Generic HIV Prevention Shot by Dr. Reddy's

The FDA granted tentative approval to Dr. Reddy's Laboratories for a generic version of a groundbreaking HIV prevention medicine, likely a long-acting injectable. This could increase access and reduce costs, but final approval may be delayed by patent or exclusivity issues. The move signals a shift toward broader availability of HIV prevention tools.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works